Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Gilbertson

Short Diagnosis-To-Treatment Interval Is Associated With High Risk and Poor Outcomes in Diffuse Large B-Cell Lymphoma

Hematological Oncology

Cancer Research

English

R-Ivac Salvage Therapy in Relapsed and Refractory DLBCL

Hematological Oncology

Cancer Research

English

Related publications

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal

English

Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis

Current Biomarker Findings

Clinical Biochemistry

English

Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies

American Journal of Hematology

English

Diffuse Large B-Cell Lymphoma

English

Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies

Cancer Research

English

Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

Blood Cancer Journal

English

Oncologist Volume and Outcomes in Older Adults Diagnosed With Diffuse Large B Cell Lymphoma

Cancer Research

English

Hitting Back at Lymphoma: How Do Modern Diagnostics Identify High‐risk Diffuse Large B‐cell Lymphoma Subsets and Alter Treatment?

Cancer Research

English

High-Risk Patients With Diffuse Large B-Cell Lymphoma Are Not Enrolled on Clinical Trials

Hematological Oncology

Cancer Research

English